Uban, Daisy .
HRN: 28-56-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/19/2026
03/26/2026
IV
750mg
Q8hrs
HAP
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: